T cells in myositis

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Malmström, Vivianne ^a   Venalis, Paulius ^a   Albrecht, Inka ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; INTERLEUKIN 21; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; AUTOANTIBODY; AUTOANTIGEN; CHEMOKINE;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DERMATOMYOSITIS; HUMAN; INCLUSION BODY MYOSITIS; INTERSTITIAL LUNG DISEASE; MEMORY T LYMPHOCYTE; MUSCLE; MYOSITIS; PLASMACYTOID DENDRITIC CELL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; BIOLOGICAL MODEL; CELL MOTION; IMMUNOLOGY; METABOLISM;

AUTOANTIBODIES; AUTOANTIGENS; CELL MOVEMENT; CHEMOKINES; HUMANS; LUNG DISEASES, INTERSTITIAL; MODELS, IMMUNOLOGICAL; MYOSITIS; T-LYMPHOCYTES;

EID: 84871700904     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4116     Document Type: Review

References (56)

1. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 2011, 13:209. 10.1186/ar3275, 3132021, 21457520.
2. Chinoy H, Lamb JA, Ollier WE, Cooper RG. Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther 2011, 13:216. 10.1186/ar3327, 3218878, 21658295.
3. Rayavarapu S, Coley W, Nagaraju K. An update on pathogenic mechanisms of inflammatory myopathies. Curr Opin Rheumatol 2011, 23:579-584. 10.1097/BOR.0b013e32834b41d2, 21960036.
4. Chinoy H, Li CK, Platt H, Fertig N, Varsani H, Gunawardena H, Betteridge Z, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG, . UK Adult Onset Myositis Immunogenetic Consortium and UK Juvenile Dermatomyositis Research Group Genetic association study of NF-kappaB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2012, 51:794-799. UK Adult Onset Myositis Immunogenetic Consortium and UK Juvenile Dermatomyositis Research Group.
5. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004, 14:337-345. 10.1016/j.nmd.2004.02.006, 15099594.
6. Stenzel W, Goebel HH, Aronica E. Immune-mediated necrotizing myopathies- a heterogeneous group of diseases with specific myopathological features. Neuropathol Appl Neurobiol 2012, 38:632-646. 10.1111/j.1365-2990.2012.01302.x, 22989019.
7. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005, 84:231-249. 10.1097/01.md.0000173991.74008.b0, 16010208.
8. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712. 10.1038/44385, 10537110.
9. Gan L, Miller FW. State of the art: what we know about infectious agents and myositis. Curr Opin Rheumatol 2011, 23:585-594. 10.1097/BOR.0b013e32834b5457, 21885972.
10. Noelle RJ, Nowak EC. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 2010, 10:683-687. 10.1038/nri2848, 20847745.
11. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum 1998, 41:2108-2116. 10.1002/1529-0131(199812)41:12<2108::AID-ART5>3.0.CO;2-Q, 9870867.
12. Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol 2009, 183:4792-4799. 10.4049/jimmunol.0803688, 19752224.
13. Baird GS, Montine TJ. Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathy. Arch Pathol Lab Med 2008, 132:232-238.
14. De Paepe B, Creus KK, De Bleecker JL. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. Ann N Y Acad Sci 2007, 1109:441-453. 10.1196/annals.1398.050, 17785333.
15. Marino M, Scuderi F, Provenzano C, Scheller J, Rose-John S, Bartoccioni E. IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. J Neuroimmunol 2008, 196:41-48. 10.1016/j.jneuroim.2008.02.005, 18400310.
16. Schmidt J, Barthel K, Wrede A, Salajegheh M, Bahr M, Dalakas MC. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 2008, 131(Pt 5):1228-1240. 2367696, 18420712.
17. Tateyama M, Fujihara K, Misu T, Itoyama Y. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis. J Neurol Sci 2009, 279:47-52. 10.1016/j.jns.2008.12.024, 19171354.
18. Lopez De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed AM. Extranodal lymphoid microstructures in inflamed muscle and disease severity of newonset juvenile dermatomyositis. Arthritis Rheum 2009, 60:1160-1172. 10.1002/art.24411, 19333937.
19. Salajegheh M, Pinkus JL, Amato AA, Morehouse C, Jallal B, Yao Y, Greenberg SA. Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve 2010, 42:576-583. 10.1002/mus.21739, 20740627.
20. Salajegheh M, Rakocevic G, Raju R, Shatunov A, Goldfarb LG, Dalakas MC. T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis. Neurology 2007, 69:1672-1679. 10.1212/01.wnl.0000265398.77681.09, 17954782.
21. Hofbauer M, Wiesener S, Babbe H, Roers A, Wekerle H, Dornmair K, Hohlfeld R, Goebels N. Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proc Natl Acad Sci USA 2003, 100:4090-4095. 10.1073/pnas.0236183100, 153053, 12651958.
22. Muntzing K, Lindberg C, Moslemi AR, Oldfors A. Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. Scand J Immunol 2003, 58:195-200. 10.1046/j.1365-3083.2003.01251.x, 12869141.
23. Benveniste O, Chérin P, Maisonobe T, Merat R, Chosidow O, Mouthon L, Guillevin L, Flahault A, Burland MC, Klatzmann D, Herson S, Boyer O. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001, 167:3521-3529.
24. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994, 152:2569-2576.
25. Fyhr IM, Moslemi AR, Lindberg C, Oldfors A. T cell receptor beta-chain repertoire in inclusion body myositis. J Neuroimmunol 1998, 91:129-134. 10.1016/S0165-5728(98)00163-5, 9846829.
26. Dimitri D, Benveniste O, Dubourg O, Maisonobe T, Eymard B, Amoura Z, Jean L, Tiev K, Piette JC, Klatzmann D, Herson S, Boyer O. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis. Brain 2006, 129(Pt 4):986-995.
27. Pandya JM, Fasth AE, Zong M, Arnardottir S, Dani L, Lindroos E, Malmstrom V, Lundberg IE. Expanded T cell receptor Vbeta-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum 2010, 62:3457-3466. 10.1002/art.27665, 20662057.
28. Waschbisch A, Schwab N, Ruck T, Stenner MP, Wiendl H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J Neuroimmunol 2010, 225:137-142. 10.1016/j.jneuroim.2010.03.013, 20537411.
29. Herrath J, Muller M, Amoudruz P, Janson P, Michaelsson J, Larsson PT, Trollmo C, Raghavan S, Malmstrom V. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur J Immunol 2011, 41:2279-2290. 10.1002/eji.201041004, 21607944.
30. Loell IM, Pandya J, Raghavan S, Zong M, Malmstrom V, Lundberg IE. Persisting CD28(null) T cells, but not regulatory T cells, in muscle tissue of myositis patients after immunosuppressive therapy. Arthritis Rheum 2011, 63:S86-S86.
31. Venalis P, Pandya J, Stache V, Nader G, Malmstrom V, Lundberg IE, Fasth A. CD28null T cells from myositis patients are cytotoxic to autologous muscle cells in vitro. Arthritis Rheum 2011, 63:S323-S324.
32. Nagaraju K, Casciola-Rosen L, Rosen A, Thompson C, Loeffler L, Parker T, Danning C, Rochon PJ, Gillespie J, Plotz P. The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol 2000, 164:5459-5465.
33. Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005, 201:591-601. 10.1084/jem.20041367, 2213068, 15728237.
34. Grassi M, Capello F, Bertolino L, Seia Z, Pippione M. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis. Clin Exp Dermatol 2009, 34:910-914. 10.1111/j.1365-2230.2009.03297.x, 19456762.
35. Solomon GJ, Magro CM. Foxp3 expression in cutaneous T-cell lymphocytic infiltrates. J Cutan Pathol 2008, 35:1032-1039. 10.1111/j.1600-0560.2007.00969.x, 18681861.
36. Antiga E, Kretz CC, Klembt R, Massi D, Ruland V, Stumpf C, Baroni G, Hartmann M, Hartschuh W, Volpi W, Del Bianco E, Enk A, Fabbri P, Krammer PH, Caproni M, Kuhn A. Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun 2010, 35:342-350. 10.1016/j.jaut.2010.07.006, 20843660.
37. Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tuting T. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 2006, 31:576-582. 10.1111/j.1365-2230.2006.02150.x, 16716166.
38. Caproni M, Torchia D, Cardinali C, Volpi W, Del Bianco E, D'Agata A, Fabbri P. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 2004, 151:784-791. 10.1111/j.1365-2133.2004.06144.x, 15491417.
39. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011, 34:108-121. 10.1016/j.immuni.2010.12.012, 3046815, 21215658.
40. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian PJ, Cordier JF. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003, 22:245-250. 10.1183/09031936.03.00026703, 12952255.
41. Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 2011, 7:343-354. 10.1038/nrneurol.2011.63, 21654717.
42. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?. Chest 2010, 138:1464-1474. 10.1378/chest.10-0180, 21138882.
43. Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis. Int J Mol Med 2006, 17:101-109.
44. Englund P, Wahlstrom J, Fathi M, Rasmussen E, Grunewald J, Tornling G, Lundberg IE. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies. Arthritis Rheum 2007, 56:372-383. 10.1002/art.22293, 17195241.
45. Levine SM, Raben N, Xie D, Askin FB, Tuder R, Mullins M, Rosen A, Casciola-Rosen LA. Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis. Arthritis Rheum 2007, 56:2729-2739. 10.1002/art.22790, 17665459.
46. Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 2012, 71:961-965. 10.1136/annrheumdis-2011-200182, 3371226, 22186711.
47. Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, Casciola-Rosen L, Härtlein M, Kron M, Yang D, Yiadom K, Dwivedi S, Plotz PH, Oppenheim JJ. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002, 196:781-791. 10.1084/jem.20020186, 2194054, 12235211.
48. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM. CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345.
49. Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y, Kuriyama T, Sueishi M, Saito Y, Iwamoto I. Activation of pulmonary T cells in corticosteroid-resistant and-sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 2002, 129:541-548. 10.1046/j.1365-2249.2002.01933.x, 1906473, 12197897.
50. Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, Fertig N, Oddis CV, Kaminski N, Rosas IO, Ascherman DP. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009, 60:2183-2192. 10.1002/art.24631, 2710404, 19565490.
51. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009, 9:491-502. 10.1038/nri2572, 19521398.
52. Krystufkova O, Vallerskog T, Helmers SB, Mann H, Putova I, Belacek J, Malmstrom V, Trollmo C, Vencovsky J, Lundberg IE. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 2009, 68:836-843. 10.1136/ard.2008.091405, 18628284.
53. Lopez de Padilla CM, Vallejo AN, McNallan KT, Vehe R, Smith SA, Dietz AB, Vuk-Pavlovic S, Reed AM. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum 2007, 56:1658-1668. 10.1002/art.22558, 17469160.
54. Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, Pachman LM. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of masT cells and mature plasmacytoid dendritic cells. Arthritis Rheum 2010, 62:2813-2822. 10.1002/art.27529, 3312790, 20506305.
55. Lundberg IE, Helmers SB. The type I interferon system in idiopathic inflammatory myopathies. Autoimmunity 2010, 43:239-243. 10.3109/08916930903510955, 20187702.
56. Borthwick NJ, Lowdell M, Salmon M, Akbar AN. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol 2000, 12:1005-1013. 10.1093/intimm/12.7.1005, 10882412.